BioCentury
ARTICLE | Financial News

KV completes debt financing

November 22, 2010 8:00 AM UTC

KV Pharmaceutical Co. (NYSE:KVA), St. Louis, Mo. Business: Drug delivery, Generics Date completed: 11/17/10 Type: Debt financing Raised: $60 million Investors: U.S. Healthcare I LLC; U.S. Healthcare I...